tiprankstipranks
Advertisement
Advertisement

Core Scientific reports Q1 Adjusted EBITDA $4.4M vs. ($6.1M) last year

Reports Q1 revenue $115.2M, consensus $109.1M. “Core Scientific (CORZ) is differentiated by our ability to combine capital readiness with speed to delivery,” said Adam Sullivan, Chief Executive Officer of Core Scientific. “We are investing ahead of contracts, advancing ready-for-service dates and moving development forward across multiple sites. That execution capability is accelerating customer discussions and reinforcing the value of our high-density compute infrastructure platform.”

Claim 55% Off TipRanks

New trading tool for CORZ bulls

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1